GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (TSE:4553) » Definitions » Shiller PE Ratio

TOWA Pharmaceutical Co (TSE:4553) Shiller PE Ratio : 11.67 (As of Mar. 02, 2025)


View and export this data going back to 2004. Start your Free Trial

What is TOWA Pharmaceutical Co Shiller PE Ratio?

As of today (2025-03-02), TOWA Pharmaceutical Co's current share price is 円2790.00. TOWA Pharmaceutical Co's E10 for the quarter that ended in Dec. 2024 was 円239.08. TOWA Pharmaceutical Co's Shiller PE Ratio for today is 11.67.

The historical rank and industry rank for TOWA Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

TSE:4553' s Shiller PE Ratio Range Over the Past 10 Years
Min: 8.44   Med: 13.29   Max: 22.66
Current: 11.67

During the past years, TOWA Pharmaceutical Co's highest Shiller PE Ratio was 22.66. The lowest was 8.44. And the median was 13.29.

TSE:4553's Shiller PE Ratio is ranked better than
83.51% of 467 companies
in the Drug Manufacturers industry
Industry Median: 23.8 vs TSE:4553: 11.67

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

TOWA Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2024 was 円163.914. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is 円239.08 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


TOWA Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for TOWA Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co Shiller PE Ratio Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.97 13.83 13.82 9.65 12.98

TOWA Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.03 12.98 12.67 13.11 14.03

Competitive Comparison of TOWA Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TOWA Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's Shiller PE Ratio falls into.



TOWA Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

TOWA Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=2790.00/239.08
=11.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TOWA Pharmaceutical Co's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, TOWA Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=163.914/110.7000*110.7000
=163.914

Current CPI (Dec. 2024) = 110.7000.

TOWA Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 43.397 97.900 49.071
201506 43.940 98.400 49.433
201509 34.794 98.500 39.104
201512 43.080 98.100 48.613
201603 25.697 97.900 29.057
201606 -22.340 98.100 -25.209
201609 24.060 98.000 27.178
201612 88.730 98.400 99.821
201703 14.477 98.100 16.336
201706 37.687 98.500 42.355
201709 43.187 98.800 48.389
201712 57.707 99.400 64.267
201803 -17.840 99.200 -19.908
201806 67.040 99.200 74.812
201809 49.070 99.900 54.375
201812 80.430 99.700 89.304
201903 56.780 99.700 63.045
201906 70.770 99.800 78.499
201909 62.050 100.100 68.621
201912 73.370 100.500 80.817
202003 66.430 100.300 73.318
202006 62.700 99.900 69.478
202009 61.860 99.900 68.548
202012 60.910 99.300 67.903
202103 84.450 99.900 93.580
202106 105.530 99.500 117.409
202109 78.100 100.100 86.370
202112 114.420 100.100 126.536
202203 18.140 101.100 19.862
202206 27.280 101.800 29.665
202209 26.790 103.100 28.765
202212 -14.384 104.100 -15.296
202303 4.400 104.400 4.666
202306 96.510 105.200 101.556
202309 44.750 106.200 46.646
202312 92.748 106.800 96.135
202403 94.560 107.200 97.647
202406 111.640 108.200 114.219
202409 21.530 108.900 21.886
202412 163.914 110.700 163.914

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


TOWA Pharmaceutical Co  (TSE:4553) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


TOWA Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


TOWA Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co Headlines

No Headlines